These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 28901475)
1. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression. Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475 [TBL] [Abstract][Full Text] [Related]
2. Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4. Lan X; Lu G; Yuan C; Mao S; Jiang W; Chen Y; Jin X; Xia Q J Cancer Res Clin Oncol; 2016 Jan; 142(1):177-85. PubMed ID: 26206483 [TBL] [Abstract][Full Text] [Related]
3. Up-regulation of TIF1γ by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-β/Smad signaling pathway. Qi G; Lu G; Yu J; Zhao Y; Wang C; Zhang H; Xia Q Eur J Pharmacol; 2019 Oct; 860():172551. PubMed ID: 31323225 [TBL] [Abstract][Full Text] [Related]
4. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition. Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942 [TBL] [Abstract][Full Text] [Related]
6. Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal. Wei M; Mao S; Lu G; Li L; Lan X; Huang Z; Chen Y; Zhao M; Zhao Y; Xia Q BMC Cancer; 2018 Apr; 18(1):434. PubMed ID: 29665787 [TBL] [Abstract][Full Text] [Related]
7. Parthenolide inhibits the tumor characteristics of renal cell carcinoma. Liu D; Han Y; Liu L; Ren X; Zhang H; Fan S; Qin T; Li L Int J Oncol; 2021 Jan; 58(1):100-110. PubMed ID: 33367934 [TBL] [Abstract][Full Text] [Related]
8. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway. Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421 [TBL] [Abstract][Full Text] [Related]
9. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246 [TBL] [Abstract][Full Text] [Related]
10. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway. Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846 [TBL] [Abstract][Full Text] [Related]
11. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway. Kou B; Liu W; Tang X; Kou Q Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866 [TBL] [Abstract][Full Text] [Related]
12. CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC. Li H; Wang S; Li X; Weng Y; Guo D; Kong P; Cheng C; Wang Y; Zhang L; Cheng X; Cui Y Cancer Sci; 2023 Jan; 114(1):91-104. PubMed ID: 36056599 [TBL] [Abstract][Full Text] [Related]
13. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway. Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793 [TBL] [Abstract][Full Text] [Related]
14. Silibinin inhibits epithelial‑mesenchymal transition of renal cell carcinoma through autophagy‑dependent Wnt/β‑catenin signaling. Fan Y; Hou T; Dan W; Liu T; Luan J; Liu B; Li L; Zeng J Int J Mol Med; 2020 May; 45(5):1341-1350. PubMed ID: 32323735 [TBL] [Abstract][Full Text] [Related]
15. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4. Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Effects of Valproic Acid Treatment on Cell Survival and Epithelial-Mesenchymal Transition-Related Features of Human Gastric Cancer Cells. Jahani M; Khanahmad H; Nikpour P J Gastrointest Cancer; 2021 Jun; 52(2):676-681. PubMed ID: 32621111 [TBL] [Abstract][Full Text] [Related]
17. In vitro anticancer activities of osthole against renal cell carcinoma cells. Liu L; Mao J; Wang Q; Zhang Z; Wu G; Tang Q; Zhao B; Li L; Li Q Biomed Pharmacother; 2017 Oct; 94():1020-1027. PubMed ID: 28810525 [TBL] [Abstract][Full Text] [Related]
18. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells. Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566 [TBL] [Abstract][Full Text] [Related]
19. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma. Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829 [TBL] [Abstract][Full Text] [Related]
20. TNF-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a GSK3β-dependent mechanism. Ho MY; Tang SJ; Chuang MJ; Cha TL; Li JY; Sun GH; Sun KH Mol Cancer Res; 2012 Aug; 10(8):1109-19. PubMed ID: 22707636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]